CompletedNCT04966923
Phenotype and Prognosis of Patients With Breast Cancer and Pathogenic Variants of TP53
Studying Li-Fraumeni syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Instituto do Cancer do Estado de São Paulo
- Principal Investigator
- Vanessa Petry, MDInstituto do Cancer do Estado de São Paulo
- Intervention
- No intervention in this study(other)
- Enrollment
- 135 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2022
Study locations (1)
- ICESP, São Paulo, Brazil
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04966923 on ClinicalTrials.govOther trials for Li-Fraumeni syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06712095Video Capsule Examination in Patients With Lynch SyndromeRoyal Marsden NHS Foundation Trust
- RECRUITINGPHASE2NCT06088030Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric CancerYang Li
- RECRUITINGNCT05126810Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic CounselingM.D. Anderson Cancer Center
- RECRUITINGNCT04541654Li-Fraumeni & TP53 (LiFT UP): Understanding and ProgressDana-Farber Cancer Institute
- RECRUITINGNCT04982744Registry of Li Fraumeni and Li Fraumeni Like SyndromesIstituto Ortopedico Rizzoli
- RECRUITINGNCT04367246Li-Fraumeni Syndrome/TP53 BiobankAbramson Cancer Center at Penn Medicine
- ENROLLING BY INVITATIONNANCT03176836Li-Fraumeni Syndrome Imaging StudyThe Hospital for Sick Children
- ACTIVE NOT RECRUITINGNANCT02950987Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition SyndromesDana-Farber Cancer Institute